Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 13/20 | 1.00 |
| ▸ | PHOSPHO1 | Q8TCT1 | 12/20 | 1.00 |
| ▸ | PMM2 | O15305 | 11/20 | 1.00 |
| ▸ | G6PD | P11413 | 5/20 | 1.00 |
| ▸ | APOBEC3G | Q9HC16 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | MAPT | P10636 | 2/20 | 1.00 |
| ▸ | PKM | P14618 | 2/20 | 1.00 |
| ▸ | HPGD | P15428 | 2/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 2/20 | 1.00 |
| ▸ | CASP3 | P42574 | 2/20 | 1.00 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 1.00 |
| ▸ | RAB9A | P51151 | 2/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 1.00 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29910151 | 1.00 | MPI (1.00) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL25763324 | 0.91 | MPI (0.89) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL1898397 | 0.85 | MPI (1.00) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL30562926 | 0.85 | MPI (1.00) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL8371772 | 0.85 | MPI (0.77) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL30738364 | 0.84 | MPI (0.96) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL1897990 | 0.83 | G6PD (1.00) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL1900552 | 0.83 | MPI (0.74) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL21033372 | 0.83 | MPI (0.74) | MPIPHOSPHO1PMM2G6PDAPOBEC3G | |
| SCHEMBL1894451 | 0.83 | MPI (1.00) | MPIPHOSPHO1PMM2G6PDAPOBEC3G |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 369 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059072-A | Backup control device and control method | 中国商用飞机有限责任公司 | 2026-05-19 | — | — | CN | claimed |
| EP-4161221-B1 | RIGID-FLEX PRINTED CIRCUIT BOARD INCLUDING BUILT-IN DIAGNOSTIC | HAMILTON SUNDSTRAND CORP (US) | 2026-05-13 | — | — | EP | claimed |
| US-12406713-B2 | Probabilistic computing devices based on stochastic switching in a ferroelectric field-effect transistor | INTEL CORPORATION (US) | 2025-09-02 | — | — | US | claimed |
| US-20250160275-A1 | COMPOUNDS FOR MODIFYING MEIOTIC RECOMBINATION AND METHODS RELATING THERETO | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2025-05-22 | — | — | US | claimed |
| CN-119792523-A | Application of KDM5B inhibitor in preparation of medicine for treating EBV-related epithelial tumors | 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） | 2025-04-11 | — | — | CN | claimed |
| EP-4492688-A1 | FAIL OPEN DETECTION | Hamilton Sundstrand Corporation (US) | 2025-01-15 | — | — | EP | claimed |
| CN-119276763-A | Test equipment and method for realizing BBF.247 based on Mini OLT | 太仓市同维电子有限公司 | 2025-01-07 | — | — | CN | claimed |
| CN-113885394-B | Airborne data comprehensive acquisition and recording system and method | 中国人民解放军海军航空大学青岛校区 | 2025-01-03 | — | — | CN | claimed |
| CN-115675914-B | PBIT circuit for testing on-state of multi-channel electric detonator | 航宇救生装备有限公司 | 2024-12-24 | — | — | CN | claimed |
| CN-118643383-A | Aircraft brake configuration identification method | 西安航空制动科技有限公司 | 2024-09-13 | — | — | CN | claimed |
| CN-115675914-A | PBIT circuit for testing connection state of multi-path electric detonator | 航宇救生装备有限公司 | 2023-02-03 | — | — | CN | claimed |
| US-11464784-B2 | Inhibition of aminocylase 3 (AA3) in the treatment of cancer | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2022-10-11 | — | — | US | claimed |
| CN-110474757-B | Signal transmission method and device, storage medium, and electronic device | 中兴通讯股份有限公司 | 2022-08-12 | — | — | CN | claimed |
| US-20220186183-A1 | NOVEL GLIA-LIKE CELLS DIFFERENATIATED FROM SOMATIC CELLS, PREPARATION METHOD THEREFOR, COCKTAIL COMPOSITION FOR PREPARING SAME, CELL THERAPEUTIC AGENT FOR PREVENTING OR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME, AND METHOD FOR PREVENTING AND TREATING NEUROLOGICAL DISORDERS BY ADMINISTERING SAME | Cellapeutics Bio (KR) | 2022-06-16 | — | — | US | claimed |
| EP-4011367-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19 | Dompe' Farmaceutici S.P.A. (IT) | 2022-06-15 | — | — | EP | claimed |
| CN-216210579-U | Airborne data comprehensive acquisition and recording system | 中国人民解放军海军航空大学青岛校区 | 2022-04-05 | — | — | CN | claimed |
| CN-113973362-A | Reinforced learning non-zero and non-cooperative multi-agent secure communication power control method | 天津大学 | 2022-01-25 | — | — | CN | claimed |
| US-20200206239-A1 | INHIBITION OF AMINOCYLASE 3 (AA3) IN THE TREATMENT OF CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-07-02 | — | — | US | claimed |
| WO-2019055825-A1 | INHIBITION OF AMINOACYLASE 3 (AA3) IN THE TREATMENT OF CANCER | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-03-21 | — | — | WO | claimed |
| US-20150272939-A1 | Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase | YALE UNIVERSITY (US) | 2015-10-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220186183-A1 | NOVEL GLIA-LIKE CELLS DIFFERENATIATED FROM SOMATIC CELLS, PREPARATION METHOD THEREFOR, COCKTAIL COMPOSITION FOR PREPARING SAME, CELL THERAPEUTIC AGENT FOR PREVENTING OR TREATING NEUROLOGICAL DISORDERS, COMPRISING SAME, AND METHOD FOR PREVENTING AND TREATING NEUROLOGICAL DISORDERS BY ADMINISTERING SAME | GMFG, HGF, BDNF | MPI 4637/4885PHOSPHO1 3836/4885PMM2 2141/4885 |
| US-20200206239-A1 | INHIBITION OF AMINOCYLASE 3 (AA3) IN THE TREATMENT OF CANCER | PLAAT3, HCCS, LAP3 | MPI 3826/4885PHOSPHO1 3805/4885PMM2 3512/4885 |
| US-11464784-B2 | Inhibition of aminocylase 3 (AA3) in the treatment of cancer | PLAAT3, HCCS, LAP3 | MPI 3826/4885PHOSPHO1 3805/4885PMM2 3512/4885 |
| US-20150272939-A1 | Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase | KDM1B, KDM1A, JMJD1C | MPI 4251/4885PHOSPHO1 3282/4885PMM2 3687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.